• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.95% Nasdaq Down 2.40%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    17.26 Down 1.25(6.75%) Jun 29, 4:00PM EDT
    |After Hours : 18.21 Up 0.95 (5.50%) Jun 29, 7:49PM EDT
    Add to Portfolio
    Prev Close:18.51
    Open:17.70
    Bid:18.20 x 3900
    Ask:18.50 x 200
    1y Target Est:25.80
    Beta:-0.92
    Next Earnings Date:N/A
    Day's Range:17.13 - 18.47
    52wk Range:2.50 - 30.13
    Volume:1,311,181
    Avg Vol (3m):1,899,090
    Market Cap:515.90M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSDown 6.75%515.90M
    DNDN 0.00%0.00
    VICL 0.00%64.01M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.53
    Quarterly EPS Est (Jul-15) :-0.35
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback